Honasa Consumer Q1 FY27 preview: Revenue Rs 639 cr

What the Q1 FY27 preview is signalling

Honasa Consumer’s Q1 FY27 results are in focus after Uniresearch published an expectations note projecting modest year-on-year growth on both revenue and profit. The estimate pegs revenue at Rs 639 crore, up 7.4% YoY, and profit after tax (PAT) at Rs 42 crore, up 2.5% YoY. With personal care demand and brand-level growth diverging across categories, the quarter is being tracked for signs of consistency rather than a one-off margin spike. The preview also matters because Honasa has reported sharper growth and profitability in recent quarters, raising the bar for delivery. Investors are also weighing management commentary around FY27 growth ambitions versus near-term execution.

Uniresearch estimate: the headline numbers

The Uniresearch preview explicitly forecasts Q1 FY27 revenue of Rs 639 crore and PAT of Rs 42 crore. It attributes the forecast to trailing analysis, estimating revenue growth of +7.4% YoY and PAT growth of +2.5% YoY. The same note uses Q1 FY26 reported numbers as the base period for comparison. The estimate, as presented, implies profit growth will trail revenue growth, pointing to a quarter where costs and investments may rise alongside scale.

Q1 FY26 base: what the forecast builds on

Honasa Consumer reported revenue of Rs 595 crore and PAT of Rs 41 crore in Q1 FY26, which Uniresearch uses as the reference for its Q1 FY27 projection. The input data in the provided context also notes that Q1 FY26 was a “steady start” with revenue at Rs 595 crore and PAT of Rs 41 crore. It also states EBITDA margin was 7.7% in Q1 FY26. Gross profit margin improved to 71.2% in Q1 FY26, up 48 bps YoY, as per the same context. These Q1 FY26 datapoints frame the Q1 FY27 estimate as a continuation of steady growth rather than an acceleration.

Recent quarter prints: why expectations are shaped higher

Beyond the Q1 base, Honasa has reported periods of faster growth and stronger profitability in other quarters referenced in the provided material. One set of quarterly financial highlights reports revenue of Rs 682 crore with 28% YoY growth, gross margin of 71.4% (up 70 bps), EBITDA of Rs 77 crore at an 11.3% margin, and PAT of Rs 69 crore (10.2% margin). Separately, another snippet notes “revenue rises to Rs 657 cr” along with “EBITDA nearly triples to Rs 77 cr”. These figures, while not tagged to the same quarter in every excerpt, collectively show a phase where margins expanded meaningfully versus earlier levels like Q1 FY26 EBITDA margin of 7.7%.

Dividend and cash distribution: a notable change

The context also mentions a dividend of Rs 3 per equity share, with total cash distribution of Rs 98 crore, described as a maiden dividend in one segment. Dividend initiation typically increases scrutiny on the durability of cash generation and profitability. It also becomes a reference point for future capital allocation choices, particularly when the company is also exploring acquisitions in new categories (as referenced in the Reuters excerpt). The combination of dividend payout and acquisition exploration is relevant because it signals multiple competing uses of cash.

Brand and category signals mentioned in the data

Operationally, the highlights provided reference growth in “focus categories” at 35% YoY in one quarterly summary, while another section cites “younger brands” growing over 40%. Mamaearth, the flagship brand, is cited as delivering “mid-teens growth this quarter” in one excerpt and “double-digit percentage range” growth for the December quarter in the Reuters excerpt. The Derma Co is referenced as maintaining a double-digit EBITDA profile, with face cleanser sales doubling in one summary. The context also notes that Honasa discontinued its ayurvedic brand Ayuga, alongside a separate mention of net profit of Rs 40.2 crore for a Q1 period.

FY26 scale-up and FY27 growth ambition

The provided material includes a longer-term financial trajectory: revenue grew from about Rs 2 crore in FY17 to about Rs 2,400 crore in FY26, with EBITDA exceeding Rs 230 crore and PAT over Rs 130 crore. It also cites “Full Year Revenue Growth: 20% Year-over-Year” and “Full Year PAT: Rs 200 crores”, along with a full-year EBIT margin of 9% and a separate mention of a 9.3% EBITDA margin for FY26. For FY27, the Reuters excerpt states Honasa aims to grow overall revenue in the high-teen percentage range, while analysts project 15% growth (LSEG-cited). That establishes a higher growth narrative at the annual level even as the Uniresearch Q1 FY27 estimate suggests single-digit YoY growth for the quarter.

Stock snapshot: valuation signals in the context

The data provided includes a valuation snapshot: Honasa Consumer is described as showing a “below-average growth signal,” with the stock trading at a P/E of 74.5 and market cap of Rs 11,518 crore. While the snippet does not provide a date for this snapshot, it provides a lens into why quarterly delivery matters. High P/E multiples typically increase sensitivity to near-term growth and margin outcomes, especially when management commentary is pointing to high-teen growth aspirations for FY27.

Key numbers at a glance

Market impact: what investors will compare this quarter against

The Q1 FY27 estimate will be read against two different baselines present in the context. One is the Q1 FY26 base of Rs 595 crore revenue and Rs 41 crore PAT, which points to steady growth. The other is the set of stronger quarterly highlights that cite Rs 682 crore revenue, Rs 77 crore EBITDA (11.3% margin), and Rs 69 crore PAT, which sets a tougher comparison in terms of margins and profit conversion. Investors also track whether gross margin stays near the low-70% range referenced (71.2% to 71.4%) and whether operating leverage sustains EBITDA margins closer to double digits. Any update on brand momentum for Mamaearth and scaling of newer brands such as The Derma Co will likely shape near-term sentiment, given the multiple growth rates cited across excerpts.

Why the Q1 FY27 numbers matter

The Q1 FY27 preview points to a quarter where revenue growth is expected to outpace profit growth. If the company continues investing in brand building and distribution while attempting to sustain gross margin, PAT expansion may remain measured even with mid-single to high-single revenue growth. The presence of a dividend announcement in the context raises expectations of disciplined cash management alongside growth investments. Separately, the Reuters excerpt on acquisitions adds an additional dimension: execution needs to balance organic growth, portfolio decisions (including discontinuations like Ayuga), and potential inorganic moves.

Conclusion

Uniresearch’s Q1 FY27 estimate for Honasa Consumer stands at Rs 639 crore revenue and Rs 42 crore PAT, building on Q1 FY26’s Rs 595 crore revenue and Rs 41 crore PAT. The quarter will be judged on whether growth stays steady while profitability remains resilient, especially after periods of higher margins and profit reported in other quarters. Investors will also watch how management commentary aligns the near-term quarterly pace with the stated high-teen revenue growth ambition for FY27 and any updates on capital allocation after the dividend and acquisition exploration references.